GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 18, 2024
Displaying entries 37601 - 37650 of 40384 in total
PDB ID UniProt ID Title Descriptor ▼
8AP6 P0DPG3 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 D0A5R7 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 P0DPG4 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 Q57VT0 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 Q387J1 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 C9ZJA0 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 Q38AG1 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 Q582T1 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 Q57Z84 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 Q38C84 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 C9ZLR9 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 Q583U4 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AP6 8AP6 Trypanosoma brucei mitochondrial F1Fo ATP synthase dimer
8AX5 P0AEX9 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881
8AX5 Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881
8AX5 O60894 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881
8AX6 P0AEX9 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882
8AX6 Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882
8AX6 O60894 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882
8AX7 P0AEX9 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448
8AX7 Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448
8AX7 O60894 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448
8DCY 8DCY CCHFV GP38 Hoti/Kosovo bound with 13G8 Fab
8DCY A0A7T6Y557 CCHFV GP38 Hoti/Kosovo bound with 13G8 Fab
8DW2 8DW2 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022
8DW2 P0DTC2 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022
8DW3 8DW3 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022
8DW3 P0DTC2 Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022
8DWA P0DTC2 Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
8DWA 8DWA Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
8DXS P0DTC2 Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
8DXS 8DXS Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
8E56 P07293 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution
8E56 P19518 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution
8E56 P13806 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone at 2.8 Angstrom resolution
8E57 P07293 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution
8E57 P19518 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution
8E57 P13806 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 100 microM MNI-1 at 2.8 Angstrom resolution
8E58 P07293 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution
8E58 P19518 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution
8E58 P13806 Rabbit L-type voltage-gated calcium channel Cav1.1 in the presence of Amiodarone and 1 mM MNI-1 at 3.0 Angstrom resolution
8E59 Q01668 Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution
8E59 P54284 Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution
8E59 P54289 Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom resolution
8E5A Q01668 Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution
8E5A P54284 Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution
8E5A P54289 Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution
8E5B Q01668 Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution
8E5B P54284 Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution
8E5B P54289 Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3.3 Angstrom resolution

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024